Skip to main content

The Interpretation of The P-Values

  • Chapter
  • 3769 Accesses

In randomized controlled trials, prior to statistical analysis, the data are checked for outliers and erroneous data. Data-cleaning is defined as deleting-the-errors / maintaining-the-outliers. Statistical tests are, traditionally, not very good at distinguishing between errors and outliers. However, they should be able to point out main endpoint results that are closer to expectation than compatible with random sampling. E.g., a difference from control of 0.000 is hardly compatible with random sampling. As it comes to well-balanced random sampling of representative experimental data, nature will be helpful to provide researchers with results close to perfection.

However, because biological processes are full of variations, nature will never allow for 100 per cent perfection. Statistical distributions can account for this lack of perfection in experimental data sampling, and provide exact probability levels of finding results close to expectation.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. SAS. www.sas.com

  2. SPSS. www.spss.com

  3. S-plus. www.splus.com

  4. Stata. www.stata.com

  5. Levin RI, Rubin DS. p-value. In: Statistics for management. Eds Levin RI and Rubin DS, Prentice-Hall, New Jersey, 1998, pp 485–496.

    Google Scholar 

  6. Utts JM. p-value. In: Seeing through statistics. Ed Utts JM, Duxbury Press, Detroit, 1999, pp 375–386.

    Google Scholar 

  7. Cleophas TJ, Zwinderman AH, Cleophas AF. p-values. Review. Am J ther 2004; 11: 317–322.

    Article  Google Scholar 

  8. Cleophas TJ, Zwinderman AH, Cleophas AF. p-values, beware of the extremes. Clin Chem Lab Med 2004; 42: 300–305.

    Article  Google Scholar 

  9. Michelson S, Schofield T. p-values as conditional probabilities. In: The biostatistics cookbook. Eds Michelson S and Schofield T, Kluwer Academic Publishers, Boston, 1996, pp 46–58.

    Google Scholar 

  10. Petrie A, Sabin C. Explanation of p-values. In: Medical statistics at glance. Eds Petrie A and Sabin C, Blackwell Science Oxford UK, 2000, pp 42–45.

    Google Scholar 

  11. Matthews DE, Farewel VT. p-value. In: Using and understanding medical statistics. Eds Matthews DE and Farewell VT, Karger, New York, 1996, pp15– 18.

    Google Scholar 

  12. Riffenburgh RH. p-values. In: Statistics in Medicine. Ed Riffenburgh RH, Academic Press, San Diego, 1999, pp 95–96, 105–106.

    Google Scholar 

  13. Cleophas TJ, Cleophas GM. Sponsored research and continuing medical education. JAMA 2001; 286: 302–304.

    Article  Google Scholar 

  14. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al., for the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755–1762.

    Article  Google Scholar 

  15. Sandham JD, Hull RD, Brand RF, Knox L, Pineo GF, Doig CJ, et al., for the Canadian Critical Care Clinical Trials Group. A randomized, controlled trial of the use of pulmonary-artery catheters in high–risk surgical patients. N Engl J Med 2003; 348:5–14.

    Article  Google Scholar 

  16. LIPID Study Group. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. Lancet 2002; 359:1379–1387.

    Article  Google Scholar 

  17. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:7–22.

    Article  Google Scholar 

  18. Parisi AF, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992; 326:10–16.

    Google Scholar 

  19. Seppälä H, Nissinen A, Järvinen H, Huovinen S, Henrikson T, Herva E, et al. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326:292–297.

    Google Scholar 

  20. Rafal ES, Griffiths CE, Ditre CM, Finkel LJ, Hamilton TA, Ellis CN, et al. Topical retinoin treatment for liver spots associated with photodamage. N Engl J Med 1992; 326: 368–374.

    Article  Google Scholar 

  21. Barrett BJ, Parfrey PS, Vavasour HM, O'Dea F, Kent G, Stone E. A comparison of nonionic, low-osmolality radiocontrast agents with ionic, high-osmolality agents during cardiac catheterization. N Engl J Med 1992; 326:431–436.

    Google Scholar 

  22. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948; 2: 769–782.

    Article  Google Scholar 

  23. Motulsky H. p-values, definition and common misinterpretations. In: Intuitive biostatistics. Ed Motulsky H, Oxford University Press, New York, 1995, pp96– 97.

    Google Scholar 

Download references

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media B.V.

About this chapter

Cite this chapter

(2009). The Interpretation of The P-Values. In: Cleophas, T.J., Zwinderman, A.H., Cleophas, T.F., Cleophas, E.P. (eds) Statistics Applied to Clinical Trials. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9523-8_10

Download citation

Publish with us

Policies and ethics